12:00 AM
 | 
Sep 15, 2008
 |  BC Week In Review  |  Company News  |  Other News

Amgen, University of Iowa cancer, autoimmune news

The university filed suit in the U.S. District Court for the Southern District of Iowa alleging that Amgen infringed the university's U.S. Patents Nos. 5,168,062 and 5,285,839. The patents cover transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequences, which are...

Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >